1. <strike id="1ap65"><i id="1ap65"><strong id="1ap65"></strong></i></strike>
        <button id="1ap65"><delect id="1ap65"><dfn id="1ap65"></dfn></delect></button>
        <sub id="1ap65"><wbr id="1ap65"></wbr></sub>
        1. CN / EN
          News center
          About us

          TechnoDerma Medicines Inc.

          Technoderma Medicines, Inc.is a clinical stage biopharmaceutical company.

          The company's current core research and development programs include innovative drugs for the treatment of androgenic alopecia, eczema/atopic dermatitis, psoriasis and lupus. TDM-105795, the world's leading small-molecule drug candidate for the treatment of androgenic alopecia, has now completed 2a clinical trials. TDM-180935, a novel JAK1/TYK2 inhibitor for eczema/atopic dermatitis, also completed a Phase 1 clinical trial in December 2023 with favorable safety results.